ATG4D anticorps (AA 326-356)

N° du produit ABIN6244157

Cet anticorps Lapin Polyclonal détecte spécifiquement ATG4D dans WB et IHC (p). Il présente une réactivité envers Humain.

Aperçu rapide pour ATG4D anticorps (AA 326-356) (ABIN6244157)

Antigène: ATG4D (Autophagy related 4D Cysteine Peptidase (ATG4D))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ATG4D est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB11866

Détail du produit anti-ATG4D anticorps

Épitope: AA 326-356

Homologie: M, Pig

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ATG4D antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 326~356 amino acids surrounding S341 of human APG4D.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. IHC-P: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Détails sur ATG4D

Antigène: ATG4D (Autophagy related 4D Cysteine Peptidase (ATG4D))

Autre désignation: ATG4D

Sujet: APG4 is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes. Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole).

Poids moléculaire: 52922

NCBI Accession: NP_001268433, NP_116274

UniProt: Q86TL0

Pathways: Autophagy